Navigation Links
New Drug Shows Significant Improvement In HIV-related Heart Condition

Latest research has shown that treatment with the oral drug bosentan (Tracleer) has led to significant improvements in an often fatal disease, pulmonary arterial hypertension ( PAH) // .

PAH is usually linked with human immunodeficiency virus infection. HIV infection is believed to cause the overproduction of endothelin, which increases the chance for small pulmonary arteries to become obstructed. This chronic obstruction leads to PAH, a condition that in most cases is the direct cause of death. Bosentan mediates the effects of excess endothelin production.

For the study 16 HIV-positive patients suffering from PAH who were treated with bosetan for 16 weeks were evaluated. Results showed there was significant improvement in survival indicators of the disease, such as six-minute walk distance and cardiac index, following bosetan treatment. However all patients suffered at least one adverse side effect of the drug including peripheral edema, headache, abnormal liver function, muscle cramps, fluid retention, and vomiting.
'"/>




Page: 1

Related medicine news :

1. Experimental treatment for Ebola Virus Shows promising results in mice
2. New Prostate Cancer Vaccine Shows Promise
3. Ebola Treatment Shows Promise
4. Greek Study Shows Living In The Hills May Be Healthier
5. Research Shows Carbon Monoxide Prevents Inflammations
6. Latest Research Shows That Multivitamins Might Not Prevent Infections In All Elderly
7. Novartis MS Drug Shows Promising Results
8. MRI Shows Emotional Changes During Menstrual Cycle
9. Bronchiolo-alveolar Carcinoma Shows Sonographic Pattern Of Pneumonia
10. AIDS drug GS 9137 Shows Promise
11. Teenager Shows Signs Of Recovery after Receiving Massive Dose of Radiation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
(Date:10/12/2017)... PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B ... York City on October 11, 2017. , The annual award competition recognizes editorial and ...
(Date:10/12/2017)... RAPIDS, Mich. (PRWEB) , ... October 12, 2017 ... ... Wellness, has been named one of Michigan’s 2017 Best and Brightest in Wellness® ... and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief ... advancements to physician colleagues, skilled nursing facility medical directors and other clinicians at ... of Wound Care." , "At many of these conferences we get to educate ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... , Oct. 4, 2017 OBP ... self-contained, illuminating medical devices, today announced regulatory approval ... Surveillance Agency (or Agência Nacional de Vigilância Sanitária ... single-use, cordless surgical retractor with integrated LED light ... access, illumination and exposure of a tissue pocket ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
(Date:10/2/2017)... Halo Labs announces the European launch of their new low volume, ... 2017 in Cambridge, U.K on October 4th. ... samples with unprecedented speed and sensitivity while using far less sample ... ... system ...
Breaking Medicine Technology: